Biotech's Takeover Protection Thanks to a Few Big Investors
May 3, 2012, 02:00 AM
by
Michael Croft
Reuters | Biotech's ability to fight off Big Pharma is due to a handful of large investors that dominate the companies' shares registries.
May 3, 2012 | Biotech's ability to fight off Big Pharma is due to a handful of large investors that dominate the companies' shares registries. Of 10 likely biotech takeover targets, four investment companies have majority shares. Reuters